KRISTY PARRISH: Open Payments
NPI 1114412525 · ATHENS, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,887 in 87 payments from 18 companies in 2025. Trend: 2023 $63 · 2024 $174 · 2025 $1,887
Food & beverage: $1,807Education: $80
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $297 |
| Novartis Pharmaceuticals Corporation | 14 | $243 |
| Amgen Inc. | 10 | $195 |
| Paratek Pharmaceuticals, Inc. | 8 | $192 |
| Regeneron Healthcare Solutions, Inc. | 7 | $173 |
| GENZYME CORPORATION | 5 | $159 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $134 |
| Janssen Biotech, Inc. | 4 | $85 |
| SANOFI-AVENTIS U.S. LLC | 1 | $80 |
| LEO Pharma Inc. | 4 | $72 |
Products named: DUPIXENT, RINVOQ, COSENTYX, OTEZLA, NUZYRA, Cabtreo, TREMFYA, ADBRY.
Industry payments across AL — which companies pay providers there.
